KRISTIN BUSSELL: Open Payments
NPI 1356533061 · CROWNSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 65 payments from 18 companies in 2025. Trend: 2023 $1,095 · 2024 $1,170 · 2025 $1,647
Food & beverage: $1,575Education: $73
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $239 |
| Neurocrine BioSciences, Inc. | 4 | $201 |
| Vanda Pharmaceuticals Inc. | 6 | $144 |
| Teva Pharmaceuticals USA, Inc. | 4 | $143 |
| Collegium Pharmaceutical, Inc. | 6 | $128 |
| Tris Pharma Inc | 5 | $97 |
| IDORSIA PHARMACEUTICALS US INC | 4 | $87 |
| Corium, LLC | 3 | $84 |
| Alexion Pharmaceuticals, Inc. | 1 | $80 |
| Otsuka America Pharmaceutical, Inc. | 2 | $65 |
Products named: CAPLYTA, INGREZZA, HETLIOZ, Jornay PM, Dyanavel XR, REXULTI, Quviviq, Azstarys.
Industry payments across MD — which companies pay providers there.
